|
|
Influence of Caffeic Acid on blood glucose concentration in rats with type 2 diabetes mellitus |
PEI Yu DONG Xu TANG Xin-yi HE Ai-hua YANG Hao ZHOU Hong ZHOU Jian-zhong▲ LI Hua-nan |
School of Biomedical Engineering,Medical University of Chongqing,the National Key Laboratory Cultivation Base Built Jointly by the Ministry and the Ministry of Education—Chongqing Key Laboratory of Ultrasonic Medical Engineering,Chongqing 400016,China |
|
|
Abstract Objective To explore the influence of Caffeic Acid on blood glucose concentration in rats with type 2 diabetes mellitus.Methods Sixty male SD rats aged 6-8 weeks were selected and fed for 3 days.Twenty rats were selected as the normal observation group and they were divided into the blank group and experimental group1-3,and there were 5 rats in each group.The experimental group 1~3 was fed with 0.4,0.6 and 0.8 g/kg of Caffeic Acid respectively,the blank group was gavaged with 1 ml/100 g of equivalent distilled water.The other 40 rats were fed with high-sugar and high-fat diet for 6 weeks and intraperitoneally injected with 30 mg/kg Streptozotocin(STZ)for 3 days,the model of type 2 diabetic rats was established,FPG>7 mmol/L and rat urine sugar test positive were considered to be successful in modeling.Thirty rats successfully modeled were randomly divided into model group,Acarbose group,combined group and Caffeic Acid group 1-3,and there were 5 rats in each group.Acarbose group was given 10 mg/kg Acarbose,combined group was given 10 mg/kg of Acarbose and 1 g/kg of Caffeic Acid,Caffeic Acid group 1-3 was given 0.8,1.0,1.2 g/kg respectively,model group was given 1 ml/100 g of distilled water.The influence of Caffeic Acid on fasting blood glucose(FPG)and insulin(INS)in rats of normal observation group was observed at different times;the influence of each drug group on the concentration of FPG in type 2 diabetic rats was observed.Results There was no significant difference in FPG concentration and INS expression level among the groups (in normal observation group)before gavage,gavage for the first,sixth day(P>0.05).There was no significant difference in FPG concentration among the groups(in model group and various drug group)before gavage(P>0.05).After gavage,compared with model group,the FPG concentration in various drug group were decreased significantly,and the differences were statistically significant(P<0.05,P<0.01).The FPG concentration in combined group was significantly lower,and the difference was statistically significant(P<0.01).Among the drug groups,the combined group had the most significant hypoglycemic effect(P<0.05).Conclusion Caffeic Acid has a reducing FPG effect on type 2 diabetic rats,but it is not as effective as Acarbose in reducing blood sugar.The effect of Acarbose combined with Caffeic Acid was the most obvious.
|
|
|
|
|
[1] |
区洪炎,阮国梅,李志成,等.甘精胰岛素联合二甲双胍治疗初发早期糖尿病肾病的疗效[J].热带医学杂志,2017,17(2):208-210.
|
[2] |
范世宏,毛玉山.利拉鲁肽联合二甲双胍治疗初诊肥胖2型糖尿病的临床效果分析[J].中国现代医生,2016,54(11):26-28.
|
[3] |
刘蓓.阿卡波糖对初发2型糖尿病患者临床疗效及胃肠道反应的影响[J].医学理论与实践,2016,29(11):1453-1454.
|
[4] |
Albarrak AI,Mohammed R,Assery B,et al.Evaluation of diabetes care management in primary clinics based on the guidelines of American Diabetes Association[J].Int J Health Sci(Qassim),2018,12(1):40-44.
|
[5] |
许晓玲.阿卡波糖联合二甲双胍治疗初发2型糖尿病伴高脂血症的疗效观察[J].中国医药科学,2017,7(21):233-235.
|
[6] |
杨文英.磺脲类药物在国内外2型糖尿病患者中的使用现状[J].药品评价,2017,14(3):7-11.
|
[7] |
施劭锋,苏广瑞,林日昌,等.不同短期强化治疗方案对初发2型糖尿病患者疗效分析[J].牡丹江医学院学报,2016,37(3):77-79.
|
[8] |
刘春花,施旻,姚凤云,等.咖啡酸锗对小鼠U14腹水瘤抑制作用的研究[J].黑龙江畜牧兽医,2016,(7):18-20.
|
[9] |
陈欣,文武,郁正亚.高糖高脂饲料联合小剂量链脲佐菌素制备SD大鼠2型糖尿病模型[J].中国医药导刊,2015,17(7):737-738,740.
|
[10] |
范金波.咖啡酸对体外抗氧化活性的研究[J].中国食品学报,2015,3(15):65-73.
|
[11] |
Hsu CC,Lin MH,Cheng JT,et al.Antihyperglycaemic action of diosmin,a citrus flavonoid,is induced through endogenousβ-endorphin in type I-like diabetic rats[J].Clin Exp Pharmacol Physiol,2017,44(5):549-555.
|
[12] |
Ferents IV,Brodiak IV,Liuta MIa,et al.Effects of decarboxylated L-arginine on morphofunctional characteristics of the erythron in experimental diabetes mellitus in rats[J].Fiziol Zh,2014,60(4):70-79.
|
[13] |
刘芳,郑文龙,罗跃娥,等.国产与进口阿卡波糖片剂治疗2型糖尿病的荟萃分析[J].中国现代医学杂志,2014,24(33):86-89.
|
[14] |
孙皓熠.咖啡酸研究概况[J].食品与药品,2017,19(2):151-154.
|
[15] |
吴磊,陆超,居文政.大鼠灌胃清热养心颗粒后血浆中咖啡酸、绿原酸药代动力学研究[J].江苏中医药,2015,47(5):74-76.
|
[16] |
戴国梁,刘史佳,李长印,等.阿司匹林对灯盏细辛注射液中咖啡酸的药代动力学影响[J].中国药理学通报,2014,30(4):570-574.
|
[17] |
陈旭.糖尿病前期患者GLP-1及胰高血糖素的分泌特点分析[J].中国城乡企业卫生,2017,32(9):107-108.
|
[18] |
邓海鹏,林凯,梨映兰,等.阿卡波糖联合维格列汀治疗老年2型糖尿病患者的效果及安全性[J].广东医学,2015,36(12)1928-1929.
|
[19] |
宁磊.阿卡波糖对2型糖尿病患者胰高血糖素的影响分析[J].临床研究,2016,10(34):104.
|
[20] |
关成山.咖啡酸类似物合成的研究进展[J].中国科技投资,2017,(13):329.
|
|
|
|